Skip to content

Efficacy and mechanism of repetitive transcranial magnetic stimulation on pain and function in patients with knee osteoarthritis

Efficacy and mechanism of repetitive transcranial magnetic stimulation on pain and function in patients with knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071311
Enrollment
Unknown
Registered
2023-05-11
Start date
2023-05-10
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

actual-rTMS group :The true stimulation group received a real high-frequency rTMS intervention with the coil tangential to the scalp and conventional treatments such as acupuncture, physiotherapy, and
Sham-rTMS group :Sham-rTMS + conventional treatments

Sponsors

The First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Age 40 years and above, regardless of gender; ?Patients diagnosed with knee osteoarthritis according to the criteria of "China Osteoarthritis Treatment Guidelines (2021 Edition)", "Osteoarthritis Treatment Guidelines (2018 Edition)"; That is, patients who meet the following criteria 1+ (any two of 2, 3, 4, 5), 1) recurrent knee pain within the last 1 month; 2) X-ray (standing or weight-bearing position) showing joint space narrowing, subchondral osteosclerosis and or cystic lesions; 3) age = 50 years; 4) morning stiffness = 30 min; 5) bone friction sound (sensation) during activity; ? those with Kellgren-Lawrence grading scale I-III for knee osteoarthritis joint degeneration; ? patients with a mean pain score of VAS = 3 in the past 1 week; ? Subjects with normal lower extremity force lines; ?Patients agreed and signed the informed consent form.

Exclusion criteria

Exclusion criteria: ? those with confirmed diagnosis of rheumatoid arthritis, gout, severe osteoporosis, tuberculosis, tumors; ? patients who have previously taken long-term drugs related to the treatment of osteoarthritis of the knee or who have undergone intra-articular injection therapy within 6 months; ? patients with combined severe heart, brain, kidney or lung dysfunction or mental illnesses that are not conducive to rehabilitation training or magnetic therapy ? patients with stroke, brain surgery, cognitive impairment, alcohol or drug abuse or other conditions or symptoms that are likely to prevent completion of the program; ? patients with a history of epilepsy, metal built into the skull, high intracranial pressure, implanted pacemakers, or other contraindications to transcranial magnetic stimulation; ? patients with a history of artificial knee arthroplasty or non-arthroscopic surgery; ? patients with poor compliance and unable to cooperate to complete the treatment; ? those who are unable to sign the informed consent form or have participated in other research projects.

Design outcomes

Primary

MeasureTime frame
Knee Dysfunction Score;Pain score;

Secondary

MeasureTime frame
Knee joint mobility;oxyhemoglobin (HbO), reduced hemoglobin (rHb), and total hemoglobin;Quality of life;Anxiety score;

Countries

China

Contacts

Public ContactMaoyuan Wang

The First Affiliated Hospital of Gannan Medical University

wmy.gmu.kf@gmail.com+86 137 6776 6152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026